Published by top news
Posted on August 26, 2021
9 min readLast updated: February 14, 2026
Add as preferred source on Google
According to the study, the Demand for Venous Procedure Devices is projected to surpass US$ 3 billion in value by the end of the aforementioned forecast period (2021 to 2031), expanding at a CAGR of around 6%. Fact.MR’s Study says demand for venous procedure catheters is expected to see considerable incline, with a preference for central catheters generating the bulk of total demand.
Historically, the market posted credible gains, being valued at around US$ 2 billion in 2019. A host of established, as well as incumbent market players, are scrambling to secure a firm footing in the landscape. An increasing number of startups are capitalizing on incremental opportunities presented by key segments across the venous procedure devices market.
For More Insights Into The Market, Request a Sample of this Report –
https://www.factmr.com/connectus/sample?flag=S&rep_id=5966
Inari Medical, for instance, offers the Flow Triever catheter-based thrombectomy device shown to extract significant amounts of clot from large blood vessels. It has a self-expanding Nitinol framework designed to engage, disrupt and remove emboli from blood vessels with minimal trauma. Likewise, Silk Road Medical produces devices for Transcarotid artery revascularization (TAR) procedure for carotid artery disease. Its products include the EnRoute Transcarotid Neuroprotection and the EnRoute Stent system.
“Purpose-built venous stents offer promising growth prospects, attributed to their ability to achieve efficient arterial pulsation and mobility for treating occlusion diseases. Hence, prominent manufacturers are collaborating with medical technology consulting firms to deepen their outreach,” comments a Fact.MR analyst.
Share Your Requirements & Get Customized Reports –
https://www.factmr.com/connectus/sample?flag=RC&rep_id=5966
Free Mindfulness Meditation Apps to Gain Trajectory Boost during 2021-2031 –
https://www.youtube.com/watch?v=MCEzxHyNzHc
Full Access of this Report Is Available at
https://www.factmr.com/checkout/5966
Medtronic Plc., Abbott Laboratories, Cook Medical, Cardinal Health, Becton Dickinson & Co. (BD), Terumo Corporation, Boston Scientific Corporation and Teleflex are some prominent venous procedure devices manufacturers. Most players rely on introducing new devices post regulatory approvals across key geographies, in addition to other expansion strategies such as collaborations, mergers & acquisitions and partnerships respectively.
For More Insights
https://www.newswire.co.kr/newsRead.php?no=927193
Fact.MR, in its new offering, presents an unbiased analysis of the venous procedure devices market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031. The study divulges essential insights on the market on the basis of product (stents, catheters, and others), application (leg, chest, abdomen, and arm), indication (vascular diseases and cancer), and end user (hospitals, ambulatory surgical centers, specialty clinics, and others) across five major regions of the world (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa).
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
According to the study, the Demand for Venous Procedure Devices is projected to surpass US$ 3 billion in value by the end of the aforementioned forecast period (2021 to 2031), expanding at a CAGR of around 6%. Fact.MR’s Study says demand for venous procedure catheters is expected to see considerable incline, with a preference for central catheters generating the bulk of total demand.
Historically, the market posted credible gains, being valued at around US$ 2 billion in 2019. A host of established, as well as incumbent market players, are scrambling to secure a firm footing in the landscape. An increasing number of startups are capitalizing on incremental opportunities presented by key segments across the venous procedure devices market.
For More Insights Into The Market, Request a Sample of this Report –
https://www.factmr.com/connectus/sample?flag=S&rep_id=5966
Inari Medical, for instance, offers the Flow Triever catheter-based thrombectomy device shown to extract significant amounts of clot from large blood vessels. It has a self-expanding Nitinol framework designed to engage, disrupt and remove emboli from blood vessels with minimal trauma. Likewise, Silk Road Medical produces devices for Transcarotid artery revascularization (TAR) procedure for carotid artery disease. Its products include the EnRoute Transcarotid Neuroprotection and the EnRoute Stent system.
“Purpose-built venous stents offer promising growth prospects, attributed to their ability to achieve efficient arterial pulsation and mobility for treating occlusion diseases. Hence, prominent manufacturers are collaborating with medical technology consulting firms to deepen their outreach,” comments a Fact.MR analyst.
Share Your Requirements & Get Customized Reports –
https://www.factmr.com/connectus/sample?flag=RC&rep_id=5966
Free Mindfulness Meditation Apps to Gain Trajectory Boost during 2021-2031 –
https://www.youtube.com/watch?v=MCEzxHyNzHc
Full Access of this Report Is Available at
https://www.factmr.com/checkout/5966
Medtronic Plc., Abbott Laboratories, Cook Medical, Cardinal Health, Becton Dickinson & Co. (BD), Terumo Corporation, Boston Scientific Corporation and Teleflex are some prominent venous procedure devices manufacturers. Most players rely on introducing new devices post regulatory approvals across key geographies, in addition to other expansion strategies such as collaborations, mergers & acquisitions and partnerships respectively.
For More Insights
https://www.newswire.co.kr/newsRead.php?no=927193
Fact.MR, in its new offering, presents an unbiased analysis of the venous procedure devices market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031. The study divulges essential insights on the market on the basis of product (stents, catheters, and others), application (leg, chest, abdomen, and arm), indication (vascular diseases and cancer), and end user (hospitals, ambulatory surgical centers, specialty clinics, and others) across five major regions of the world (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa).
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
A central venous catheter is a long, thin tube inserted into a large vein in the neck, chest, or groin to administer medication, fluids, or to collect blood samples.
Thrombectomy is a surgical procedure to remove a blood clot from a blood vessel, often performed using specialized devices like catheters.
Venous stents are small mesh tubes inserted into veins to keep them open and improve blood flow, often used in treating occlusions.
CAGR, or Compound Annual Growth Rate, is a useful measure that indicates the mean annual growth rate of an investment over a specified time period longer than one year.
Explore more articles in the Research Reports category
